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The mechanisms which regulate feeding behavior and energy balance are evaluated in 
order to gain new ideas and insight.  The importance of this regulatory system within 
society, which faces the issue of obesity, is discussed.  A better understanding of the 
feeding behavior regulatory system is sought in order to allow for the development of 
clinical treatments that promote health.  Thorough analysis of the literature about the 
regulatory mechanisms of feeding behavior is performed, to develop new approaches and 
insight into obesity.  The brain/gut communication network, hormone signaling, 
microbiota, and non-hypothalamus/gut communication systems are evaluated using an 
integrated approach.  This knowledge could have potential value for clinical therapies to 
resolve the obesity issue. Current knowledge, unanswered questions, and new 
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 Humans must consume food in order to obtain the energy necessary to carry out 
biological processes.  This food energy allows us to perform the metabolic processes that 
are essential for life and function.  It is, therefore, quite important to achieve a balance 
between energy intake and energy utilization, through regulated eating behavior.  
Insufficient food consumption and nutrition is harmful, but the consumption of excess 
food is also harmful.  The consumption of excess food causes increases in body weight, 
as the excess energy must be stored.  This energy is stored, generally in the form of 
adipose or fat tissue, which can lead to obesity.  Obesity, in which body fat levels are 
above healthy standards and the Body Mass Index is greater or equal 30, presents a 
variety of health risks and issues.  Obesity is a world-wide epidemic that has major 
effects on people’s health and quality of life, with some estimates showing over 30% of 
people in America are considered obese (Nguyen & El-Serag, 2010).  Thus, for 
understanding the relationship between feeding behavior and body weight regulation, it is 
important to understand the mechanisms through which feeding behavior and energy 
balance are regulated at the cellular and molecular level. 
Feeding behavior is regulated through a complex system of interactions between 
the brain and gut, which utilizes neural and hormonal signaling mechanisms.  The 
stomach and gut must communicate with the brain so that food intake is regulated in a 
way that provides sufficient, but not excess caloric intake.  Therefore, appropriate feeding 
must correspond to its physiological metabolic energy needs.  The interactions between 
the digestive system and the brain determine how food products are processed once 
consumed.  Given the fundamental importance of this brain-gut metabolic network, and 
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its great relevance to the issue of obesity, knowledge of the mechanisms of this system is 
quite valuable.  The brain/gut network shown in Figure 1, depicts the brain and 
gastrointestinal components, which communicate through neural and hormonal 
connections.  This network depends on strong communication between the organs within 
the abdominal region and the brain region, through hormone and neural signals.  
Information is recognized in a variety of ways, including through G-protein coupled 
receptors, such as GPR 119, as shown.  Great study has been conducted to evaluate this 
powerful biological system, but many of the details about the neuronal and molecular 
pathways as well as metabolic processes that regulate feeding behavior and energy 
homeostasis are not fully understood (Morton et al. 2006). 
 
Figure 1. Gut-brain communication.  The hypothalamus, located in the brain, together 
with the gastrointestinal system, including the stomach (which stores food) and the 
intestines are important to regulate feeding behavior.  These organ systems are connected 
via nerves (such as the vagus nerve) and hormonal interactions. 
Adapted from Sam et al. (2011) 
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       The neural and hormonal components of the feeding behavior regulatory system have 
been evaluated through scientific experimentation, which includes chemical, 
pharmacological, and other methods.  Neuronal cells within the brain and nervous system 
recognize and transmit signals indicating energy status.  The brain, and particularly the 
hypothalamic region, recognizes hormonal and peptide signals (Belgardt et al 2009), 
which provide the means through which the stomach and brain can communicate hunger 
or satiety conditions, and thus govern eating behavior.  In response to differing food 
energy levels within the body, different chemical signals provide messages to the brain to 
regulate eating. The peptide hormone ghrelin is produced in the stomach and pancreas, 
and acts on cells within the hypothalamus to stimulate hunger (Dietrich & Horvath, 
2011).  Another hormone called leptin produces a satiety signal through its binding to 
cells in the hypothalamus’s arcuate nucleus (Dietrich & Horvath, 2011).  Additionally, 
the hormone insulin works to store food-derived products, such as glucose.  Through 
hormone interactions and cell signaling such as these, the brain and gut communicate 
energy needs and regulate feeding behavior.  A more complete understanding of these 
complex interactions between hormones, neurons, and gastrointestinal cells could have 
real clinical and academic value. 
       The other component of the gastrointestinal system that provides increased 
complexity to the energy homeostasis regulatory system is the presence of intestinal 
microbiota.  These microbiota, which provide organisms with a unique bacterial 
microbiome, have a large role in the processing of food products and energy metabolism 
(Backhed et al. 2004).  It has been shown through bacterial compositional studies that the 
microbiota found in obese individuals is different compared to the microbiota found in 
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the intestines of lean individuals (Ley et al. 2006), which suggests a function for them in 
the body-weight regulatory process.  Specifically, lean individuals have a higher 
proportion of Bacteroidetes than obese individuals (Ley, 2006).  With these roles, and 
their relationship with biological hormones, microbiota may also be involved in the 
regulation of feeding behavior.  This relationship is uncertain, but insight into these 
interactions is important and useful. 
 An additional dimension to the feeding behavior regulatory system is provided by 
the influence of factors outside of the main brain/gut communication system.  These 
factors include the sensory and physiological mechanisms that affect animals’ behavior 
and metabolism.  Organisms exist within the context of their environment, and so the 
sensory signals obtained by organisms from the environment, such as olfactory, visual, 
and taste cues, have effects on feeding behavior.  Eating and body weight regulation is 
also affected by biological clocks, which has a large impact on the metabolic processes.  
This clock is located in the suprachiasmatic nucleus (SCN), which is outside of the 
hypothalamus of the brain that is important in brain/gut communication (Mistlberger, 
2011).  This study shows the functional importance of other brain regions, outside of 
what are considered the main brain/gut communication pathways, in affecting feeding 
behavior. It has been shown that obese individuals are more stimulated to overeat in 
response to certain external cues, such as food portion size or appearance, displaying the 
importance of external factors in controlling eating (Herman & Polivy, 2008).  Therefore, 
the feeding behavior regulatory system must be evaluated within the context of external 
cues and brain regions outside of the direct brain/gut communication system. 
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 This thesis project will provide a more complete understanding of the 
mechanisms through which feeding behavior is controlled in mammas.  The thesis seeks 
to evaluate the complex metabolic pathways and biological processes through which 
hormones provide communication between the brain and gut to coordinate appropriate 
feeding behavior, and the possible role of gut microbiota within this framework.  This 
system of interactions acts through an integrated system of biological mechanisms and 
pathways.  This system works within a context of external sensory signals, as well as 
physiological signals outside of the main brain/gut communication system.  A solid 
understanding of the regulatory system that controls feeding behavior, using this 
integrated and coordinated approach, has not been well developed.  By viewing the entire 
synchronized system within the context of a whole organism, a more practical and 
valuable understanding of the feeding behavior regulatory system can be obtained.  This 
understanding can provide knowledge that is relevant to the societal issues of obesity and 
body weight control (Morton et al. 2006).  Gaining insight into the unanswered questions 
regarding the neural and hormonal mechanisms of feeding behavior regulation, and 
developing a cohesive and integrated understanding of this regulatory system are the 
goals of this thesis. 
 This thesis will be conducted using a literature based research approach.  A 
thorough collection of research will be obtained, and examined to gain new insight and 
provide an integrated perspective about feeding behavior regulation within mammals.  
This integrated approach is distinctive and different from the literature, and is most useful 
to provide clinically relevant knowledge.  Knowledge about the neuronal circuits, 
gastrointestinal cells, hormone signals, gut microbiota, etc. will be gathered and 
6 
 
assimilated into a more complete view of the system as an interacting whole, rather than 
separate components.  The writing of the thesis is organized into chapters to first discuss 
the current knowledge of each subject, then introduce an unanswered question, and 
finally to provide insight/answers about the question.  The knowledge provided by this 
thesis project will add to the current understanding of the regulation of feeding behavior 
and metabolic disorders, such as obesity, which are important for society. 
 
Literature Review 
Given the importance of feeding behavior and maintaining a proper energy balance in 
body weight regulation and overall health, many scientific studies have been conducted 
to explore the underlying neural and molecular mechanisms. Moreover, recent studies 
(Backhed et al. 2004) in humans and rodents have shown that communication between 
the brain and microbiota present in the digestive tract is important for fat storage, adding 
more complexity to the system of body weight control.  These factors work within the 
context of external and sensory cues, and in combination with mechanisms outside the 
main brain/gut communication mechanism, in order to produce a comprehensive system 
of feeding behavior regulation. 
Hormones and the Feeding Behavior Regulatory System- 
The hormone leptin, was discovered in 1994 (Zhang et al. 1994) and signals the 
nutritional status of mammals. Leptin circulates throughout the body, and acts on the 
hypothalamus by inhibiting excessive food intake (Farooqi & O’Rahilly 2009). Issues 
with leptin, such as leptin deficiency and leptin resistance have been attributed to obesity 
within humans (Farooqi & O’Rahilly 2009). While some of the pathways through which 
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leptin act to regulate feeding behavior are known, studies have not been conducted to 
determine all of these pathways or to develop the complete range of therapies to combat 
obesity using leptin-related treatments. 
In addition to leptin, other hormones, such as ghelin and insulin have active roles 
within the feeding behavior and energy balance control systems. In a study by Tschop et 
al. (2000) the hormone ghrelin was found to promote adiposity within rodents. This study 
involved the introduction of ghrelin into mice by injection, and determined the role of 
ghrelin within the energy balance control system. Thus, metabolic hormones such as 
ghrelin and leptin signal hunger and satiety signals, respectively, and stimulate synaptic 
processes within neuronal circuits in the hypothalamus to control feeding behavior. 
However, although these hormones play important roles in regulating metabolic 
processes in fat tissues (leptin is among others secreted from fat deposits) and the 
stomach (ghrelin is secreted from the stomach), there are neurons receiving these 
hormonal signals and responsible synaptic changes that occur in these neurons. These 
neurons that express Agouti-related protein (Agrp) are a population of neurons in the 
hypothalamic arcuate nucleus (Arc), and increasing their activity is sufficient to induce 
voracious feeding behavior (Aponte et al. 2011). While another population of neurons 
that express propiomelanocortin (Pomc) and form a neuronal circuit with Agrp-
containing neurons, inhibits feeding behavior.  
An important recent study by Yang et al. (2011) recognized how neuron memory 
circuits can be flip-flopped between these feeding states (voracious feeding, and 
inhibition of feeding) based on physiological signals (hunger and satiety). This study was 
performed in vitro using electrophysiological, pharmacological, and optogenetic 
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techniques. The study determined that in response to hunger and ghrelin, a pre-synaptic 
pathway involving an AMP-activated kinase (AMPK)-dependent pathway, regulates the 
neural activity of Agrp-containing neurons. However, this study does not determine if 
such results are consistent with in vivo studies, which is currently a major question in the 
field. Moreover, the study did not identify the pre-synaptic cells that undergo AMPK-
dependent changes to stimulate Agrp-containing neurons. 
Insulin, a hormone secreted by the pancreas, has key roles in the metabolism of 
glucose within the body and is affected by an integration of factors, including nutritional 
status and neural factors (Seino et al. 2011).  Insulin has a large role in the removal of 
glucose from blood, and obese individuals often have hyperinsulinemia, in which blood 
insulin levels are too high (Kissebah et al. 1982).  A study done by Polonsky et al. (1988) 
showed that higher Body Mass Index (BMI) measurements corresponded with higher 
levels of insulin secretion, rather than weaker insulin clearance.  These findings suggest a 
role for insulin in the regulation of body weight, and potentially in the control of feeding 
behavior. 
There are additional components involved with the complex system of feeding 
behavior and energy homeostasis regulation.  Peptide tyrosine tyrosine (PYY), Glucagon-
like peptide-1 (GLP-1), and Oxyntomodulin (OXM) have been shown to control appetite 
and/or reduce food consumption (Batterham et al. 2002; Tang-Christensen et al. 2001; 
Dakin et al. 2001).  Additionally, cholecystokinin (CKK) has been shown to reduce food 
intake in rodents upon peripheral administration (Antin et al. 1975), and pancreatic 
peptide (PP) injection has been shown to reduce food intake and reduce body weight gain 
(when administered for six days) (Asakawa et al. 2003).  Glucagon, which increases 
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energy expenditure and increases satiety, has interesting clinical potential in the treatment 
of obesity (Nair, 1987; Schulman et al. 1957).  Overall, there is a variety of signals that 
work together to control feeding behavior and energy homeostasis, and it is important to 
understand how they all interact. 
It can be seen that these studies leave much room for expanded evaluation to answer 
these questions. In addition, as communication must occur between the digestive and 
diverse neuronal systems, it is very important that the neurons and the pathways 
performing the communication functions are defined accurately. The interactions 
between the various hormones, such as ghrelin, leptin, and insulin, are also not 
completely understood. Each of these hormones has major implications for feeding 
behavior and energy homeostasis, and understanding precisely where and how these 
hormones act is a subject of much interest. 
Microbiota and the Regulation of Feeding Behavior and Energy Homeostasis- 
There is potential to improve the understanding of how microbiota act on fat storage 
and body weight control. Gut microbiota, which are the bacterial microbiome within the 
gastrointestinal tract, have been found to have important roles in the processing and 
metabolism of food products.  A recent study by Backhed et al. (2004) determined the 
importance of gut microbiota in determining the energy processing and storage of 
consumed items by rodents.  This study found that the levels of fat deposition within 
mice were affected by the levels and variety of microbiota within the gut.  The study 
involved the manipulation of mice (and their microbiota) and the analysis of metabolic 
and physical composition effects. Interestingly, not only obese mice, but also obese 
humans were shown to have a different diversity of bacteria in their intestine in 
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comparison to lean individuals (Ley et al. 2006). The study was important, but left 
questions about the potential for modifying microbiota by diet or exercise. The important 
discovery that microbiota can be modified by a mice’s physical condition was made by 
Ley et al. (2005). This study revealed the potential for obesity therapies that involved 
modification of gut microbiota. However, the question remains how such modifications 
occur at the molecular and neural level and how well such results could be translated to 
humans. Moreover, normal microbiota in mice has been associated with the development 
of the brain and anxiety-like behaviors (Neufeld et al. 2011), and thus it would be 
interesting to establish if feeding behavior is directly controlled by microbiota as well. If 
it is expected that microbiota do affect feeding behavior, through what mechanisms 
(hormonal, molecular, etc.) would they be carried out?  Altogethere these fundamental 
questions still need to be answered, and this thesis project will provide possible answers 
and valuable insights into these questions. 
Influence of Factors Outside of the Hypothalamus/Gut Communication System- 
       While a main communication network exists between the brain’s hypothalamus and 
the gut (with a variety of related hormone signaling mechanisms), the regulation of 
feeding behavior exists within a context of sensory cues and additional physiological 
mechanisms.  Eating decisions are subject to sensory cues received by the environment, 
which can include olfactory, visual, and taste cues.  It has been shown that overweight 
individuals respond to sensory (olfactory, visual, taste, etc.) cues to food without 
regulating or limiting consumption, while normal-weight individuals decreased food 
intake (Jansen et al. 2003).  However, the implications of external sensory cues and their 
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interactions within the physiological mechanisms of feeding behavioral control are not 
completely understood. 
 Feeding behavior is also affected by physiological processes that are not strictly 
within the hypothalamus/gut communication system.  The circadian clock has important 
effects on the metabolism of food and energy. This clock is located in the brain’s 
suprachiasmatic nucleus (SCN), and affects the rhythm and timing of many biological 
processes.  However, the exact location and extent of cells involved with a food 
anticipatory clock is largely uncertain (Mistlberger, 2011).  These cells, which likely 
could work through oscillations, may correspond with the mammal’s hunger status and 
help coordinate feeding behavior.  This clock may also interact with the metabolism of 
hormones, including the metabolism of ghrelin and leptin (Mistlberger, 2011), indicating 
the importance of the circadian clock in feeding behavior and energy homeostasis. 
The knowledge that has been obtained about the mechanisms of feeding behavior and 
energy homeostasis regulation is significant. However, an integrated understanding of the 
entire system has not been adequately developed. A lack of understanding of the whole-
organismal and interacting system of feeding behavior and energy homeostasis regulation 
has been an obstacle in the field and an obstacle towards the development of health care 
applications using such knowledge (Morton et al. 2006). This thesis seeks to answer the 
questions that have come about and provide an integrated understanding of the regulatory 
system of feeding behavior and energy homeostasis. 
Chapter 1- Understanding the Brain/Gut Network 
Current Knowledge About the Brain/Gut Network 
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       In order to understand the mechanisms through which feeding behavior is regulated 
in organisms, it is necessary to understand the details about the organ systems involved.  
The regulatory system utilizes brain and gut neuroendocrine communication signals to 
promote or reduce eating.  Peripheral signals from the gut and signals from the central 
nervous system interact to coordinate eating and maintain body weight. 
Within the central nervous system, the brain’s hypothalamus and brainstem are of 
particular importance, as they function as centers that receive peripheral hormone signals 
depicting the body’s nutritional status (Murphy & Bloom, 2006). The hypothalamus’s 
arcuate nucleus (ARC) has a major role, being composed of medially located appetite 
stimulating neurons (orexigenic) (Bewick et al., 2005) and laterally located appetite 
inhibitory neurons (anorexigenic) (Elias et al., 1998).  These neurons release their 
signals, such as neuropeptide Y and Agouti-related protein (AgRP) (orexigenic), or 
alpha-melanocyte stimulating hormone (alpha-MSH) derived from pro-opiomelanocortin 
(POMC) and other precursor polypeptides.  The ARC nucleus can receive circulating 
hormone signals directly, as its neurons have axon terminals located near the median 
eminence of the brain, which does not have a complete blood-brain barrier (Peruzzo et 
al., 2000).  Within the brainstem, the nucleus tractus solitaries (NTS) receive 
gastrointestinal signals from the vagal nerves, which carry such signals to the 
hypothalamus.  The NTS recognize gut hormones, which can reach the NTS through the 
circumventricular organs (which do not have complete blood-brain barriers) (Baraboi et 
al., 2010).  Additional signals can reach the brainstem from the gut through the ascending 
vagal nerve pathways (Jobst et al., 2004).  Thus, the hypothalamic ARC receives hunger 
and satiety signals through several tracks, which can be processed and used to 
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communicate intra-hypothalamic (such as the hypothalamic paraventricular nucleus) and 
extra-hypothalamic energy homeostasis actions. 
       It has been found that the brain’s hypothalamic region, primarily through AGRP and 
POMC neuron activity, utilizes a process of synaptic plasticity, in which the neurons are 
set to their appropriate state based on the hormones signals that they receive (Yang et al. 
2011).  In this neuronal circuit, an Amp-activated kinase (AMPK) positive feedback loop 
in response to ghrelin, plasticity was induced to persistently activate AGRP neurons 
(inducing a memorized feeding state).  However, in response to leptin, this feeding 
activity was switched off, through an opioid receptor-dependent pathway (suggested 
opioid release from POMC neurons) (Yang et al. 2011).  The hypothalamic circuit, seen 
in Figure 2, depicts the AgRP neurons which receive the glutamate signal, along with the 
surrounding neurons and signals, such as calcium and opioids.  It is thus seen that a 
memory circuit system is utilized by the hypothalamus in response to physiological state, 
with hunger status being switched by a flip-flop mechanism (Yang et al. 2011). 
 
Figure 2.  Hypothalamic feeding circuit.  Ghrelin is recognize by Ghsr1 receptors on 
neurons, which then release glutamate to AgRP neurons.  This process stimulates 
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feeding, which is reversed by the hormone leptin.  Feeding is induced by AgRP neurons 
and NPY, while POMC neurons are involved with satiety.  It is the identity of the 
neurons that release glutamate that is unknown. 
Adapted from Dietrich & Horvath (2011). 
 
Consumed food enters through the mouth, and upon transport through the 
esophagus, enters the stomach to be further digested.  Food is then largely processed 
within the stomach and small intestine.  The functions of the gastrointestinal tract must 
include digestion as well as the corresponding function of communicating the 
hunger/energy needs of the body.  Cells within this system, enteroendocrine cells, 
compose a major endocrine complex within the body, releasing many different hormones 
and peptide signal types (Sjolund et al., 1983).  From stem cells located within the 
intestines, enteroendocrine cells form into different varieties to express their different 
products.  It seems that enteroendocrine cells are differentiated from two branches, from 
which different product types (substance P/serotonin vs. GLP-1/PYY/NT/CCK) are 
produced (Roth et al., 1992).  While these gastrointestinal enteroendocrine cells release 
signals, they also obtain information about the gut’s contents and food needs.  The gut’s 
cells have been shown to have receptors that recognize food related signals, such as 
amino acids (Jang et al., 2007; Rozengurt et al., 2006).  This ability is extremely 
important to allow the gastrointestinal system to sense the presence of food contents, and 
coordinate the appropriate feeding behavior and appropriate metabolic response.  Various 
nutrient molecules are thus chemically recognized by the various enteroendocrine cells, 
which then can release the corresponding signals to the brain.  It is recognized that these 
enteroendocrine cells can be activated through mechanisms similar to taste receptor cells 
in the tongue.  Additional signals are received by these gastrointestinal cells through 
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physical and neural mechanisms.  The stomach is equipped with neural sensory 
mechanisms that react to the tension, stretch, and/or volume of the stomach in response to 
food (Cummings and Overduin, 2007).  It is generally accepted that the stomach’s main 
methods of recognizing satiety are more volumetric, while those of the intestines are 
chemical.  These mechanisms provide the gastrointestinal system with the powerful and 
necessary ability to recognize food contents and energy needs within the body.  In turn, 
the cells of the gastrointestinal tract coordinate such information into appropriate 
metabolic and feeding behavior responses through subsequent communication with the 
brain using hormones and peptides.  Through this integrated communication system 
between the brain and gut, involving chemical, neural, and physical mechanisms, food 
can be detected, metabolic needs can be determined, and proper eating behavior can be 
promoted. 
Unanswered Questions About the Brain/Gut Network 
By understanding this brain/gut system more completely, clinical and 
pharmacological treatments for obesity can be developed.  There are questions that exist 
in the study of this system, whose answers could be valuable for the scientific community 
and society as a whole.  The exact nature of the neural cells from which the ghrelin 
induced glutamate release originated is still unknown (Yang et al. 2011).  From which 
neurons these glutamate signals are released in order to activate AgRP neurons at their 
ionotrophic glutamate receptors in response to ghrelin, is an important piece of 
knowledge.  The identity of these pre-synaptic cells is unknown, but can likely be 
identified through evaluation of the known information about the brains’ neurons’ 
structures and functions.  Gaining insight into this question is one focus of this thesis.   
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Additionally, it is known that gastrointestinal cells can recognize food 
components using mechanisms similar to those used by taste receptor cells on the tongue.  
Specifically, it is known that intestinal cells contain sweet and bitter taste receptors, 
which means the gastrointestinal tract can sense nutrients (sweet and bitter type nutrients) 
through mechanisms similar to the tongue’s mechanisms of taste sensation.  However, it 
is not known whether or not the salty, sour, or umami type taste receptors of the tongue 
are also utilized by the gastrointestinal tract in a nutrient sensing capacity.  Whether the 
enteroendocrine cells can recognize the signals from these salty, sour, and umami taste 
molecules is an important question that should be answered.  By evaluating the literature 
dealing with the gastrointestinal cell receptors and tongue taste receptor cells, insight into 
this major question can be gained, which could allow for therapeutic treatments that 
manipulate these mechanisms to be developed.  Gaining this type of insight about 
enteroendocrine cell functioning is another focus of this thesis.   
Providing insight into the question about the pre-synaptic cells involved in the 
ghrelin response and the question of gastrointestinal cell receptor mechanisms should 
advance the field of knowledge and improve the potential for clinical obesity treatments. 
Insight/Answers About the Brain/Gut Network 
 The identity of the neural cells that carry out the glutamate release in response to 
ghrelin in order to activate the AgRP neurons is not known. These neural cells must be 
able to both recognize ghrelin, and respond to ghrelin with a glutamate release.  
Additionally, these glutamate-releasing neurons must be able to reach the AgRP neurons 
in order to promote feeding behavior.  With these criteria, the identity of these neurons 
can be better understood and determined.  The major cell receptor type within mammals 
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that recognizes the hormone ghrelin as the endogenous ligand is the growth hormone 
secratagogue (GHSR) class of receptors (Martin-Pastor et al., 2010).  This means that the 
neurons that are recognizing ghrelin, according to the model by Yang et al. (2011), likely 
contain these receptors (See Figure 2).  The presence of these receptors has been found in 
different regions of the brain, including in the important hypothalamic neurons (Zigman 
et al., 2006).  Interestingly this study by Zigman et al. (2006) also found the presence of 
GHSR mRNA within nuclei of the vagus nerve.  These locations for the ghrelin 
receptors, especially those within the hypothalamus, could make them excellent neurons 
used for the activation of AgRP neurons.  These ghrelin receptor containing neurons must 
additionally have the ability to activate AgRP neurons through an AMPK-mediated 
calcium release.  This implies a location for these cells that is relatively close to the 
AgRP neurons of the hypothalamic arcuate nucleus, if they are to be identified as 
responsible for the ghrelin induced feeding response.  Different neural inputs have been 
determined to connect with the arcuate nucleus of the hypothalamus.  It has been found 
that neurons within the forebrain and the brainstem (including the lateral parabrachial 
nucleus, ventrolateral medulla, etc.) have extensions that enter the hypothalamic arcuate 
nucleus (Li et al., 1999).  It is possible that these connections allow for corresponding 
cells from within the brainstem to stimulate AgRP neurons to induce feeding in response 
to ghrelin.  However, it seems likely that the unidentified cells have a closer proximity to 
the hypothalamus and the AgRP neurons within it.  An understanding of which neurons 
contain ghrelin receptors, which also have connectivity to the hypothalamus is key to the 
identification of the neurons that mediate the ghrelin induced feeding response via a 
release onto AgRP neurons.  Visual mapping of AgRP neurons within the hypothalamus 
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show the presence of astrocyte cells and POMC neurons in the area around AgRP 
neurons (Dietrich & Horvath, 2011).  Perhaps, it is possible that one of these cell types is 
responsible for the ghrelin induced release (if they have ghrelin receptors and the ability 
to activate AgRP neurons).  However, additional studies which provide a detailed view of 
the area around and the synaptic geography of the AgRP neurons could be useful in 
determining the precise identity of these pre-synaptic cells that stimulate AgRP and 
induce feeding.  An interesting approach that has been used to map connections and 
inputs into the hypothalamus has involved the virus mapping method, which allows for 
retrograde tracing of inputs from specific neurons (DeFalco et al., 2001).  Perhaps this 
approach could be used to determine the exact neurons that connect to the hypothalamus 
AgRP neurons.  Other potential experiments could potentially involve the selective 
inhibition of certain neural cell types, in order to view the resulting effects on ghrelin 
sensitivity and feeding behavior.  With the knowledge of the identity of these neuronal 
cells, therapies that reduce their ghrelin sensitivity or reduce their glutamate release could 
potentially be developed, which would reduce the strength of AgRP neuron activation 
and should reduce feeding behavior.  Additionally, these types of studies could be 
utilized to understand the mechanisms and pathways used by the leptin and POMC 
neuron system to flip the feeding circuit to the opposite position (satiety). 
 Determining the use of salty, sour, and umami taste cell receptors within the 
gastrointestinal system for nutrient sensing could also have clinical importance.  Since it 
is known that sweet and bitter taste receptors, which use G protein-coupled receptors 
(GPCR), such as GPR 119 (see Figure 1), are found both within the mouth/tongue and 
the gastrointestincal cells (Sternini et al., 2008), it seems possible that this oral to 
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gastrointestinal parallel extends to the use of salty, sour, and umami taste receptors as 
well.  It would seem that there would be an advantage to the utilization of similar 
receptor types within the gastrointestinal tract compared to the oral cavity with respect to 
salty, sour, and umami, just as there is for sweet and bitter receptors.  These receptor 
types are fast acting, as can be seen with their quick activation within the mouth, having 
near immediate recognition of tastes within the mouth.  It seems logical that such taste 
receptors within the gut would then be advantageous for each type of taste as well.  
However, these connections do not prove that these types of receptors are utilized within 
the gut to sense salty, sour, and umami nutrient types, making experimental observations 
quite valuable. 
       It has been shown that taste chemosensing within the gastrointestinal tract is largely 
carried out by GCPRs (Geraedts et al., 2011).  There is evidence that umami taste 
receptors also use G protein-coupled receptors (Behrens & Meyerhof, 2011).  This could 
mean that it is very possible that umami may be sensed in the gut using mechanisms 
similar to those used by the mouth and tongue, similar to sweet and bitter tastes.  It is 
important to note though that umami is a unique taste, which is produced by the 
glutamate (amino acid related), and so it utilizes multiple receptor types (Yasumatsu et 
al., 2009), which could make it unique compared to sweet and bitter tastes.  However, the 
sensing mechanisms used by for sour and salty tastes do not utilize GPCRs (Roper, 
2007).  Interestingly, sour taste recognition is conducted largely through acidification and 
acid sensitive membrane proteins (Roper, 2007).  Salty taste recognition has been 
connected to epithelial sodium channels, which is unique compared to sweet, bitter, and 
umami tastes (Roper, 2007).  Given the different mechanisms used by the salty and sour 
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taste, compared to the GPCR mechanism of the other tastes, the parallel between oral and 
gastrointestinal sensing for these tastes may not be quite as strong.  The gut and oral 
environments are quite different, and perhaps the mechanisms (more ion related) used to 
receive salty and sour signals within the oral system do not translate directly to the 
gastrointestinal system, as they more or less do for sweet, umami, and bitter tastes.  
Testing methods which knock out the genes encoding for the different oral receptor types, 
and then allow for the resulting gastrointestinal sensing of the different tastes to be 
observed could be useful.  If tests show that the knockout of a certain receptor type 
reduces taste sensing in the oral system and the gastrointestinal system, then it would be 
suggested that similar mechanisms are used in sensing that corresponding taste at each 
level (oral and gastrointestinal). 
       Nutrient and taste sensing within the gastrointestinal system is important in 
coordinating the feeding behavior of mammals.  The sensing of each nutrient and taste 
type within the stomach enables hormonal and neural signals to be sent to the brain in 
order to promote behaviors.  It is important that food products are sensed properly so that 
satiety signals are produced at the appropriate time, in order to prevent overeating.  
Therapies which can manipulate nutrient sensing, perhaps via taste receptor mechanisms, 
could be of value in promoting proper feeding behavior. 
 
Chapter 2- Hormones and Chemical Mechanisms of Communication 
Current Knowledge About the Hormones and Chemical Mechanisms of Communication 
A primary method utilized for communication purposes and cell signaling within 
the brain/gut axis is gut hormone and peptide release (See Figure 1).  A variety of 
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peptides are released by the gastrointestinal tract, which contribute to physiological 
processes in different ways.  These peptides have been found to regulate the body’s 
feelings of hunger or satiety, and food nutrient processing.  In response to the presence of 
nutrients and the distension of the stomach, gastrointestinal cells release these peptides 
which can signal the central nervous system (Sam et al. 2011).  Of central importance are 
the gut hormones Peptide tyrosine tyrosine (PYY), Glucagon-like peptide-1 (GLP-1), and 
oxyntomodulin (OXM), which are important mediators of feeding behavior (Sam et al. 
2011).  Additionally, the hormones ghrelin and leptin play major roles in regulating 
feeding behavior and the body’s physiological status as satisfied or hungry.  These 
hormones are further discussed in Chapter 1 of this thesis, as they are the major hormones 
involved with the proposed flip-flop mechanism (Yang et al. 2011).  The gut peptides 
PYY, GLP-1, and oxyntomodulin are key components of the body’s regulatory system of 
feeding behavior, and so an understanding of these hormones and their mechanisms of 
action could have real clinical and therapeutic value. 
Current Knowledge about PYY 
Peptide tyrosine tyrosine (PYY) is a 36-amino acid peptide that exists in two 
forms, which vary slightly due to an enzymatic cleavage at the peptide’s amino terminal 
location (Medeiros and Turner, 1994).  PYY is located in enteroendocrine cells in the 
stomach and intestines, with high levels of PYY found in the colon and rectal areas 
(Adrian et al. 1995).  PYY is released from gastrointestinal enteroendocrine cells into 
circulation in a proportional response to caloric intake (Adrian et al. 1985).  The presence 
of PYY within circulation has been shown to have anorectic effects, causing reduced 
food intake and weight gain (Vrang et al. 2006).  PYY is thought to reduce feeding 
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behavior via its action on the hypothalamic ARC’s Y2 receptor.  PYY has been found to 
bind to these Y2 pre-synaptic inhibitory receptors that are found on NPY neurons of the 
ARC, which prevents NPY activation and reduces feeding behavior (Batterham et al. 
2002).  Additionally, PPY seems to exert its effects on the hypothalamus through a vagal 
brainstem pathway, in which PYY is detected by Y2R receptors of the vagus nerve (Koda 
et al. 2005).  Other anorectic effects from PYY may be due to its ability to delay gastric 
emptying, decrease secretions from the pancreas, and increase absorption of electrolytes 
and fluids by the ileum (Savage et al. 1987; Symersky et al. 2005).  It is important to 
understand these mechanisms through which PYY exhibits its reducing effects on feeding 
behavior, to allow for obesity and feeding control pharmacological therapies. 
Unanswered Question about PYY 
The major issue faced by the scientific community regarding PYY as an anti-
obesity therapy is developing an effective way to deliver the peptide to the body.  The 
peptide must be delivered in a way that promotes its anorectic effects, while not inducing 
nausea or other side effects (Zac-Varghese et al. 2011).  Subcutaneous delivery of PYY 
was tried, but provided no real effect on food intake (for unclear reasons).  The 
administration of PYY utilizing a nasal spray approach is a possibility, but getting 
through the mucociliary barrier is difficult for some larger peptides (Zac-Varghese et al. 
2011).  Additionally, when delivered nasally, PYY was found to induce nausea and other 
abdominal side effects, perhaps due to rapid absorption (Zac-Varghese et al. 2011).  
Given that PYY works naturally within the gut through action on the gut vagal afferents, 
the use of orally delivered PYY has seemed appropriate.  However, it is difficult to 
deliver the PYY orally in a way that is not disrupted by the acidic gastric environment or 
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by degradative enzymes from the pancreas.  This means that PYY must be somehow 
modified or facilitated in order to allow intestinal absorption, while maintaining the 
integrity of the peptide and its desired effects (Zac-Varghese et al. 2011).  It can be seen 
that PYY has potential as an anti-obesity treatment, but faces some hurdles that must be 
overcome regarding its method of therapeutic delivery.  Therefore, a goal of this thesis 
research is to provide insight into how PYY can best be administered to induce its desired 
effects on feeding behavior. 
Insight/Answers about PYY 
 Oral intake of PYY allows for increases in the blood concentrations of the PYY 
peptide, occurring through gastrointestinal absorption.  The efficacy of absorption 
through the gastrointestinal tract and the fact that PYY works and is released naturally 
within the gut, likely make oral intake the most appropriate delivery method (as opposed 
to nasal, intravenous, or some other method) (Beglinger et al., 2008).  It is through this 
absorption that PYY’s feeding reduction effects occur.  To be effective therapeutically, 
the PYY administered must be in an appropriate dose.  Specifically, it seems important 
that the plasma PYY concentrations after oral intake would need to be higher than the 
PYY concentrations that occur naturally with a meal. Otherwise, the effects of 
therapeutic PYY would be comparable to PYY’s natural effects, and feeding behavior 
regulation would show little real change.  However, side effects of PYY administration 
(nausea, abdominal discomfort, etc.) are dose dependent, specifically in regards to the 
plasma concentrations of the drug.  To avoid these side effects, a proper dosage that 
provides for reduced feeding behavior, while not exceeding the general range that 
induces side effects (plasma concentration of about >350 pg/ml) could be found.  It 
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seems quite possible that an intermediate dosage value between the minimum needed to 
induce desired results and the maximum dosage value possible without producing 
unwanted side effects could be found.  Additionally, perhaps there could be potential to 
administer the PYY in fractional dosages, rather than all at once, as peak concentrations 
within the blood were reached after about 15-35 minutes (Beglinger et al., 2008).  
Perhaps, by introducing PYY at different times, the plasma concentration levels could be 
kept within the acceptable range, while allowing for sustained controlled feeding 
behavior.  As low blood PYY concentrations have been associated with obesity and 
increased eating, it is important to maintain adequate PYY in circulation (Karra et al., 
2009).  Another approach could possibly involve simultaneous administration of the 
PYY, along with other drug(s) (such as antiemetic drugs or others) meant to minimize the 
side effects of the PYY.  These approaches could help combat the issue of side effects 
related to PYY intake. 
       The issue of degradation of PYY within the gastrointestinal tract also affects the 
clinical potential of PYY to reduce feeding behavior and help treat obesity.  Orally 
administered PYY is degraded largely by proteolytic enzymes within the stomach.  One 
approach to solving this degradation problem could be additional administration of 
substances that effectively prevent the formation or release of these digestive enzymes 
within the stomach and intestines.  However, shutting off an entire class of enzymes 
simply to administer PYY would be much too intrusive and extreme, with great potential 
for unintended consequences.  It, therefore, seems that the best approach would be to 
manipulate the PYY delivery mechanism itself, rather than the body’s natural response to 
the PYY.  By coating the PYY with an enteric coating, its full release could be delayed 
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until the intestine is reached, where proteolytic activity is milder.  The main issue with 
this approach is the delay in the absorption of the PYY, which could make its clinical 
effects less meaningful.  To solve this issue, it seems possible that the PYY could be 
delivered with the enteric coat earlier than it would otherwise be delivered.  By timing the 
delivery of the PYY and allowing early oral intake of enteric coated PYY (perhaps at 
some point prior to feeding), the peptides’ clinical effects could be achieved at a suitable 
an appropriate time.  The other PYY delivery approach utilizes an agent-based method, in 
which peptides are noncovalently interacted with small organic molecules that can act as 
carriers (Beglinger et al., 2008).  By utilizing specific organic molecules that can most 
effectively interact with the PYY peptide, allow absorption into the bloodstream, and 
then dissociate from the peptide, PYY could be delivered effectively.  To do so, organic 
molecules that noncovalently bond to the PYY and increases PYY lipophilicity could be 
utilized.  An evaluation of the organic molecules that are most suitable delivery agents 
for specific peptides, such as PYY, would therefore be quite useful.  By understanding 
these pharmacological principles related to PYY, the peptide can be delivered effectively 
through the oral pathway. 
 The additional degradation of PYY within the blood stream, largely by 
metalloendopeptidases, gives PYY a short half-life (Addison et al., 2011).  Degradation 
makes it more difficult to achieve sustained results from PYY.  This could perhaps be 
combatted with multiple deliveries of PYY.  Additionally, inhibitors of these degradative 
metalloendopeptidases could be further studied.  By further testing the effects of these 
inhibitors, PYY’s half-life and therapeutic sustainability could be enhanced. 
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       The salivary region (tongue, etc.) has been found to contain PYY hormone and 
receptors, which can promote decreased feeding behavior (Acosta, et al., 2011).  By 
utilizing this approach to delivery, perhaps in combination with the oral approach, PYY 
can be delivered effectively.  This salivary approach would avoid the issue of degradation 
within the gastrointestinal tract by enzymes.  By combining salivary delivery with an oral 
delivery (such as enteric coated PYY), a sustainable reduction in feeding could be 
produced.  This combination approach has potential, and evaluation of possible 
combinations between the two delivery methods could be of value. 
Current Knowledge about GLP-1 
Glucagon-like peptide-1 (GLP-1), a 30 amino acid peptide released from 
gastrointestinal cells, is also an important gut hormone involved with the regulation of 
feeding behavior.  GLP-1 is released into circulation in response to glucose consumption, 
and acts as both an incretin (MacDonald et al. 2002) and as an inhibitor of glucagon 
(Willms et al. 1996), allowing it to reduce blood glucose levels after a meal.  GLP-1 also 
acts to delay gastric emptying and induce satiety effects (MacDonald et al. 2002).  GLP-
1, similar to PYY, acts on the hypothalamic ARC, PVN, and supraoptic nucleus 
(Shughrue et al. 1996), allowing it to reduce food intake significantly.  These effects 
seem to be fairly dependent on the dosage level, and reach the hypothalamus through 
vagal and brainstem pathways (Imeryuz et al. 1997).  GLP-1 is degraded in circulation by 
the DPP-IV enzyme, and so native GLP-1 has not been suitable for clinical use.  
Mimetics of native GLP-1 have been developed, including exenatide (a synthetic version 
of exendin-4), which have been shown to last longer in circulation and have weight loss 
effects (in addition to reduction in blood glucose effects).  However, while GLP-1 
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variants may provide clinical value in the treatment of obesity, they have been associated 
with nausea and abdominal side effects (Astrup et al. 2011).  It is therefore seen that 
GLP-1 has potential clinical value for obesity, but there are issues that must be resolved. 
Unanswered Question about GLP-1 
In order for GLP-1 to be an effective obesity treatment, it must be delivered in a 
way that allows it to be long acting (not degraded), and not nausea inducing.  To deal 
with the issue of GLP-1 degradation in circulation, longer lasting analogues have been 
developed.  However, some of these analogues (such as liraglutide) have been shown to 
have nausea side effects, in addition to their weight loss effects (De Silva & Bloom, 
2012).  Interestingly, nausea seemed to decline as the duration of the therapy was 
increased.  The other solution to the issue of degradation was to inhibit the enzyme DPP-
IV, which caused GLP-1 degradation.  However, this method allowed for little overall 
effects on weight loss, which was likely due to DPP-IV’s role in activating other 
anorectic hormones (De Silva & Bloom, 2012).  Therefore, it seems that some form of 
GLP-1, administered with an effective and careful dosage, provides a valuable potential 
for obesity treatment.  Therefore, a goal of this thesis is to provide insight into how GLP-
1 can be delivered in a way that provides effective results (longer lasting), with minimal 
side effects. 
Insight/Answers about GLP-1 
       The issue of rapid GLP-1 degradation and inactivation can be achieved through the 
use of inhibitors against the degradation enzymes or through the usage of resistant GLP-1 
incretin analogues.  As GLP-1 is largely degraded by dipeptidyl peptidase IV (DPP IV), 
inhibitors of this peptidase seem like a good target to enhance GLP-1’s activity.  
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However, this brings the potential issue of enhanced activation for additional peptides 
such as NPY and others, which are also degraded by DPP IV (Mentlein, 2009).  To 
combat this effect, it is possible to additionally administer specific inhibitors for these 
other peptides, which could prevent the unwanted effects associated with some of these 
other peptides.  Therefore, further study about what types of molecules can be used to 
specifically inhibit each of the gastrointestinal peptides could be conducted.  By 
determining specific inhibitors which can bind to only specific peptides with unwanted 
side effects, DPP IV inhibitors can be used to maximize the therapeutic effects of GLP-1. 
       The use of GLP-1 receptor agonists, such as liraglutide and exentatide has been 
shown to promote weight reduction (Spellman, 2012).  However, the usage of such 
agonists was associated with nausea, vomiting, and diarrhea (Spellman, 2012).  
Interestingly, the side effects of the injected drugs seemed to be fairly transient, with 
about 10% or less percentages of patients who exhibited nausea after 8-10 weeks of 
treatment with the GLP-1 analogues (Madsbad, 2009).  This could allow for the dosage 
level of the drugs could be adjusted over time, with milder dosages to begin the 
treatment.  This could possibly allow patients to begin the use of the drugs in low dosages 
to avoid side effects and increase the dosage over time as the body becomes more 
acclimated.  It may be possible to administer drugs that combat such side effects along 
with the administration of the liraglutide and exenatide.  However, careful consideration 
is needed to ensure that such combination remain effective in promoting weight loss, do 
not develop toxicities when combined, and are suitable for the individual patient.  
Additionally, it has been found that GLP-1 receptors are found throughout the body, 
within the periphery and central nervous system (Hayes et al., 2010).  Therefore, it may 
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be possible to direct GLP-1 at specific receptors in order to avoid possible side effects.  
Perhaps it is only certain GLP-1 receptors, which due to their location or other 
characterstics, are susceptible to the induction of adverse side effects.  A useful 
experiment could try to target specific GLP-1 receptors of distinct locations and type, and 
evaluate the resulting effects of food intake and adverse side effects.  If there are different 
levels of feeding reduction and/or side effects associated with each GLP-1 receptor 
group, then this strategy of specific GLP-1 receptor targeting could have real importance 
and value.  In addition to beneficial effects on body weight, the GLP-1 agonists, such as 
exenatide, also can produce beneficial effects on the cardiometabolic system of obese 
individuals (Kelly et al., 2012).  It seems therefore that in addition to weight loss, the 
GLP-1 agonists have additional benefits to the risks associated with obesity.  Therefore, 
strategies such as these described, which can reduce the side effects of GLP-1, while 
maintaining efficacy, should be of real interest to the health community. 
 
Current Knowledge about OXM 
Oxyntomodulin (OXM) is a 37 amino acid peptide released by enteroendocrine 
cells in proportional response to caloric consumption, which is known to delay gastric 
emptying, reduce gastric acid secretion, and decrease food intake (Sam et al. 2011).  
OXM has been found to coordinate its anorectic effects through hypothalamic pathways, 
specifically through the GLP-1 receptor (Baggio et al. 2004).  Its anorectic effects using 
this receptor are similarly powerful to GLP-1, despite its lower affinity for the GLP-1 
receptor (Dakin et al. 2001), and its usage of different hypothalamic pathways.  Given its 
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strong anorectic effects, OXM has potential for usage as a therapeutic agent to treat 
obesity within the population. 
Unanswered Question about OXM 
While oxyntomodulin’s anorectic effects have been shown, its exact mechanisms 
of action are uncertain.  Its use of the GLP-1 receptor is suggested, but it seems likely 
that its action may involve a distinct population of receptors or a subpopulation of the 
GLP-1 receptor (Sam et al. 2011).  This is because the presence of a GLP-1 antagonist 
within the ARC, blocked OXM’s anorectic effects, but not those of GLP-1 (Dakin et al. 
2004).  In order to realize OXM’s value as an anti-obesity treatment, its mechanism of 
action must be determined and understood.  Therefore, providing insight into OXM’s 
mechanism of action is a goal of this thesis research. 
Insight/Answers about OXM 
 The mechanism of action of OXM likely utilizes some distinct class of GLP-1 
type receptors or some OXM specific receptor class.  Interestingly, OXM has been found 
to have cardiovascular effects (increased heart rate), which occur without the use of GLP-
1 receptors (Sowden et al., 2007).  This was suggested by the fact that mice lacking the 
GLP-1 receptors exhibited heart rate increases in response to OXM just as strongly as 
mice with GLP-1 receptors.  Additionally, it has been shown through magnetic resonance 
imaging tests, that OXM and GLP-1 have distinct hypothalamic activation patterns 
(Chaudhri et al., 2006).  Interestingly, both OXM and GLP-1 were found to both increase 
neuronal activity within the brainstem (Parkinson et al. 2009).  Perhaps, this could mean 
that a common GLP-1 type receptor is present within the brain stem, while independent 
receptors are used to recognize the different peptides within the hypothalamus.  Given 
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that OXM contains the whole glucagon structural sequence, it seems likely that some 
type of glucagon receptor is utilized by OXM (Sowden et al., 2007).  With these results 
related to the cardiovascular effects of OXM, it seems quite possible that similar 
principles are found for OXM’s feeding behavior effects.  Interestingly, it has been found 
that the structural manipulation of OXM could produce analogues with enhanced binding 
to GLP-1 receptors, larger decreases in feeding, and reduced enzyme degradation (Druce 
et al., 2009).  Additionally, other manipulations were found to decrease receptor affinity 
with different effects on OXM’s anorectic capabilities.  Interestingly, it has been shown 
that OXM can exert its gastrointestinal effects even with its structure minimized to its C-
terminal octapeptide fragment (Carles-Bonnet et al., 1996).  This could suggest that in 
addition to GLP-1 receptors which bind OXM, other receptors with affinity for the OXM 
C-terminal fragment may be involved with promoting its anorectic effects.  Further study 
could involve determining the exact types of receptors that have such affinity, which 
could promote a gastrointestinal response.  By determining the presence of other such 
receptors, particularly within or near the brain/gut communication axis, OXM’s 
mechanism of action could be better understood.  Given the OXM induced reduction in 
activity within the arcuate, supraoptic, and paraventricular nuclei of the hypothalamus, it 
seems likely that various forms of OXM receptors may exist within the hypothalamus 
(Chaudhri et al., 2006).  The development of an OXM analogue that can be recognized by 
the full extent of potential OXM receptors could have the ability to promote increased, 





Chapter 3- Gut Microbiota and Feeding Behavior 
Current Knowledge About Gut Microbiota and Feeding Behavior 
Within the gastrointestinal tract of humans live large populations of microbes, 
which have important roles in the processing and digestion of food products.  The two 
major groups of bacteria within the human gut are the Bacteroidetes and Firmicutes, and 
their relative proportions have major effects on a person’s body weight and composition 
(Ley et al. 2006).  More specifically, it has been found that lean individuals have a higher 
relative proportion of Bacteroidetes than obese people.  Additionally, with weight loss, 
and low calorie consumption, this proportion of Bacteroidetes increases (Ley et al. 2006).  
This evidence shows a very important role for gut microbiota in the regulation of body 
weight, and suggests its potential role in the regulation of feeding behavior.  It can, 
therefore, be seen that manipulation of gut microbiota may have clinical importance as an 
anti-obesity treatment, through regulation of feeding behavior or energy metabolism. 
       It has been shown that the microbiota within the gut has profound implications for 
individuals’ susceptibility towards obesity and individuals’ food energy processing.  
Additionally, it has been shown that microbiota have profound effects on the central 
nervous system, with particular behavior implications (Grenham et al. 2011).  Figure 3 
depicts the gut/brain network with respect to the gut microbiota.  This system is 
connected via neural and immunity system based connections.  Specifically, microbiota 
within the gut have been associated with neurochemical changes within the brain, and 
have been shown to correlate with anxiety-like behavior (Neufeld et al. 2011). This 




Figure 3. Microbiota and the brain/gut network.  There is communication between the 
brain and gut, which allows the gut microbiota to have behavioral implications.  These 
connections are mediated through neural and immune system mechanisms. 
Adapted from Collins & Bercik (2009) 
 
Unanswered Question About Gut Microbiota and Feeding Behavior 
The influence of gut microbiota specifically on feeding behavior is relatively 
uncertain.  There is evidence that gut microbiota may be able to communicate with the 
brain through vagal neurons, and evidence suggests gut microbiota is able to affect brain 
development (Tehrani et al. 2012).  Given this evidence and these roles for gut 
microbiota, it seems possible that the gut microbiota may have a role in regulating 
feeding behavior.  This could enhance the manipulation of gut microbiota as a potential 
anti-obesity treatment.  Therefore, providing insight into whether the effects of the gut 
microbiota on the central nervous system and behavior extend to feeding behavior is a 
goal of this thesis. By evaluating the gut microbiota within the context of the central 
nervous system and the brain/gut communication axis, insight into its role in feeding 
behavior regulation can be gained. 
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Insight/Answers About Gut Microbiota and Feeding Behavior 
 There is strong evidence that the microbiota within a mammal’s gastrointestinal 
tract has real influences on behavior.  Studies have shown that variations within the 
microbiota, such as with the introduction of new bacterial types, are able to exert 
influences on behavior (such as with the induction of anxiety like behavior) (Collins & 
Bercik, 2009).  Additionally, variable behavioral responses and stress responses were 
shown in comparisons of germ free mice and mice with microbiota (Collins & Bercik, 
2009).  Given that the microbiota is located within the gastrointestinal tract, and the 
control of behavioral function is conducted by the brain, some type of communication 
must be occurring between the two in order to allow microbiota to affect feeding 
behavior (See Figure 3).  In particular, it can be proposed that through some mechanism, 
microbiota likely has influence on the neurons within hypothalamus, where feeding 
behavior is largely controlled.  It seems quite likely, that the primary mechanisms of this 
communication are through neural and immune-system mediated mechanisms.  Neuronal 
mechanisms are the major communication source of the nervous system, making their 
role within this microbiota-brain network quite likely.  Given the immune system’s 
importance in regulating non-self cell types (such as microbiota) and the importance of 
the immune system within the gut, an immune mediated mechanism is also quite likely to 
play a role in allowing microbiota to control feeding behavior. 
 The major neural pathway connecting the microbiota and the central nervous 
system is likely the vagus nerve.  It has been shown that microbiota induced behavior 
changes were not exhibited by mice that had been vagotomized (Bravo et al. 2011).  
Through neural branches, information from the vagus nerve is able to enter the brainstem, 
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and in turn reach the hypothalamus.  It seems likely that vagal signaling pathways are 
able to communicate the presence and activity of the different microbiota population.  
Interestingly, the vagus nerve has also been found to play a role in transmitting immune 
function information from the gastrointestinal tract to the brain (Wang et al., 2002).  As 
the microbiota is sensitive to the presence of food molecules within the gastrointestinal 
tract, feeding behavior regulation is a likely extension of this vagal mediated microbiota-
brain communication network. 
 An immune system mediated connection between the gut and the brain is likely a 
key player in the regulation of feeding behavior.  The gastrointestinal tract contains a 
great deal of very active and important gut-associated lymphoid tissue (GALT), which is 
responsible for regulating the contents of the gut, monitoring non-self molecules, and 
inducing an appropriate immune response.  This GALT system is meant to process 
antigen signals, in order to distinguish the different molecules as requiring or not 
requiring an immune response.  Interestingly, it has been shown that some microbiota 
molecules mimic important neuropeptides (Fetissov & Dechelotte, 2011).  The immune 
system, including the GALT, utilizes cytokine (protein signal molecules), to send 
messages and promote immune responses.  It has been shown that cytokines from the 
immune system, such as interleukin-1, are able to influence the neuroendocrine functions 
of the hypothalamic-pituitary-adrenal axis (Turnbull & Rivier, 1999).  This means that 
there is bi-directional communication between the immune system and the nervous 
system, which allows each to have influences on the activities of the other.  Perhaps it is 
possible that the presence or activity of certain microbiota could induce an immune 
response that affects neuropeptides that regulate feeding behavior, such as neuropeptide 
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Y and Agouti-related peptide (AgRP).  An immune response that stimulates neuropeptide 
Y or AgRP release, or inhibits satiety neuropeptides, could in turn stimulate feeding.  
This makes possible the idea that the lymphoid tissue of the gut is able to exert influences 
on feeding behavior in response to gut microbiota. 
 A key factor that allows an immune mediated mechanism of feeding behavior 
regulation via the microbiota-brain communication is the potential for mimicry between 
microbiota molecules and neurons and neuropeptides (Fetissov & Dechelotte, 2011).  
This means that the immune system can recognize certain microbiota as foreign and 
potentially develop an immune response to such molecules.  However, with mimicry, the 
immune system can become primed to respond to molecules of neurons or neuropeptides 
(due to their similarity to microbiota proteins).  This means that the immune system could 
greatly change the activity and presence of key neuropeptides and neurons within the 
nervous system.  It has been found that auto-antibodies have been able to bind selectively 
to alpha-melanocyte stimulating hormone (alpha-MSH) neurons (Fetissov et al., 2002).  
This was found in patients with anorexia nervosa and/or bulimia nervosa patients (who 
exhibit minimized eating/ thin body composition).  Therefore, it seems possible that such 
an auto-immune response to these neurons may have been correlated or a cause of the 
reduced eating behavior and eating disorders.  By connecting these facts, it seems 
possible that gut microbiota could prime the immune system to carry out an auto-immune 
response against neurons or neuropeptides that could result in excessive feeding behavior.  
Perhaps excessive feeding behavior could result from an auto-immune response against 
neurons that produce neuropeptide Y, AgRP, or other appetite stimulatory neuropeptides.  
This excessive eating would occur if the immune response against such cells had a 
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stimulatory effect.  On the other hand, perhaps an immune response could damage and/or 
inhibit the activity of appetite controlling neurons and neuropeptides, such as POMC 
neurons.  The inhibition of these neurons could also result in increased eating.  Through 
these mechanisms, the immune response from the GALT, resulting from priming by the 
gut microbiota, could affect the neurons that regulate feeding behavior and in turn 
influence eating.  Further evaluation into what types of immune responses (cytokine, 
chemokine, antibodies, etc.) can target hypothalamic neurons could be useful.  It is 
important to recognize which gut microbiota molecules are potentially able to promote 
auto-immune responses against these neurons.  This understanding could allow for 
medical therapies that manipulate such immune responses, in order to promote proper 
eating and body weight regulation within humans. 
 
Chapter 4- Feeding Behavior Regulation Outside of the Main Hypothalamus/Gut 
Network 
Current Knowledge About Sensory Factors in Feeding Behavior Regulation 
While communication along the main network between the hypothalamus and the 
gut plays a central role in the regulation of feeding behavior, there are factors outside of 
this axis that are also important.  The gut/hypothalamic axis works within a physiological 
context with many different interacting processes and pathways.  Therefore, one must 
recognize the presence of factors outside of this gut/hypothalamic axis in the system of 
feeding behavior regulation.  These important factors include sensory cues (visual, 
olfactory, taste) and the circadian clock.  These factors affect behavior in relation to food 
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and affect hormone metabolism, respectively, making them quite relevant to the study of 
feeding behavior regulation. 
       Mammals make decisions regarding feeding within a context of environmental cues 
that are sensed through taste, olfaction, and visual mechanisms.  The brain has sensory 
mechanisms that recognize taste, visual, and olfactory signals, independently from the 
individual’s hunger or satiety status (Rolls, 2005).  However, the behavioral response to 
these sensory cues is largely modulated by the hunger/satiety status of the individual 
(Rolls, 2007).  Thus, there is an interactive relationship between sensory cues and hunger 
status, relating to the regulation of eating. 
The sensory mechanisms related to feeding are primarily located within the 
brain’s cerebral cortex, and their signals help determine an individual’s response to food 
and corresponding behavior.  Within the primary taste cortex, primates have neurons that 
recognize the different tastes (sweet, salty, bitter, sour, umami), and also factors such as 
food temperature, viscosity, etc. (Rolls, 2007).  Additionally, primates have an additional 
secondary cortex that responds to more specific tastes (Rolls, 2007).  It is important to 
note that the primary taste cortex mechanism does not control appetite or the reward 
value of food, but only recognizes the presence of these tastes.  The reward value 
provided to the different taste sensations is greatly affected by hunger, with hunger 
promoting the reward value and pleasantness of the food (Rolls, 2007).  With increased 
consumption of food, the reward value and pleasure associated with such food and its 
corresponding tastes begin to decrease.  This occurrence seems to be quite food specific, 
as consumption to satiety of one food decreases the neuron response towards that food, 
with less of a neuron response decrease in other food/taste types (Rolls, 2007).  It is 
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believed that the decrease in pleasure provided by a food stimulus is regulated by 
decreased neuronal activity within the caudolateral orbitofrontal cortex taste area and the 
lateral hypothalamus, rather than a decrease in neuronal activity within the frontal 
opercular cortices, insular taste cortices, or the solitary tract nucleus (Rolls, 2007).  This 
shows the separation between sensory and reward systems in response to food and taste 
cues.  From these sensory signals and other satiety signals however, the orbitofrontal 
cortex receives signals about the value of food, which can allow for a corresponding 
decision about feeding behavior (Rolls, 2007).  Interestingly, reduced orbitofrontal cortex 
volume, has been associated with disinhibited eating and obesity within individuals 
(Maayan et al. 2011).  It is seen that the orbitofrontal cortex has a major role as a center 
of convergence between olfactory, taste, and visual sensory cues (and satiety 
information), and thus is of great importance to the treatment of obesity and excessive 
food consumption. 
       Olfactory sensory inputs seem to have a strong relation to taste inputs, with both 
inputs having a combined effect on taste/flavor of foods.  Olfactory neurons are located 
within the orbitofrontal cortex area of the brain and other regions, and help recognize 
odor signals, while affecting taste signals (Rolls, 2007).  Olfaction has been linked to an 
organism’s hunger status, with specific neurons having decreased activity following 
consumption of specific corresponding foods.  It has been found that individuals receive 
less olfactory pleasure from foods that have been eaten to satiety, compared to other 
foods and compared to the same food prior to consumption (Rolls, 1997).  An implication 
of this finding is that the presence of a variety of foods and flavors can promote increased 
feeding behavior, and thus obesity.  Therefore, there is a connection between the 
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olfactory response to food and an individual’s opinion of a food, which thus affects 
eating behavior decisions (Rolls, 2007).  In a study by Jansen et al. (2003), it was shown 
that overweight children responded to the odors of pleasant food by overeating, compared 
to lean children.  This shows the importance of sensory cues in promoting or decreasing 
eating behavior.  With the specific olfactory sensitivity adjustment made in response to 
specific foods, it can be seen that foods’ olfactory sensory cues can strongly influence 
eating behavior. 
Visual sensory cues about food are processed by visual neurons within the 
orbitofrontal cortex and other cortex areas of the brain.  These neurons additionally show 
olfactory and taste sensing capabilities, with visual sensing being most active in response 
to food in the presence of hunger (Critchley & Rolls, 1996).  With these functions, visual 
sensory neurons play a role in the selection of food and flavor, and visual cues can 
influence the perceived flavor of a food.  This is due to the convergence of sensory 
information that occurs largely within the orbitofrontal cortex of the brain, which allows 
interaction between sensory neuron signals.  For example, with the visual presence of 
cheese, the corresponding flavor and odor of cheese would generally be perceived as 
pleasant.  However, without the visual stimulus from cheese, the same odor or flavor 
could likely be considered unpleasant (Rolls, 2007).  Therefore, visual stimuli and the 
visual sensory neuron system have an important role in the control of feeding behavior 
and have potential clinical value in the treatment of obesity in society. 
Unanswered Question About Sensory Factors in Feeding Behavior Regulation 
Sensory mechanisms that control feeding behavior could have great clinical value 
in the treatment of obesity.  Over time, sensory responses to food have increased (at a 
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society level), while satiety signals in response to eating have been unchanged, which has 
led to increased pleasure received from food, increased overeating, and increased obesity 
(Rolls, 2007).  The importance of the brain’s orbitofrontal cortex as a center of 
information convergence between sensory cues and satiety signals is recognized.  
However, the mechanisms through which the orbitofrontal cortex processes satiety and 
sensory cues in order to induce a behavior response towards food are uncertain.  A 
method of ensuring that satiety signals are not overridden by sensory cues (within the 
orbitofrontal cortex) would have great clinical value in the treatment of obesity.  
Therefore, it is a goal of this thesis to provide insight into how to ensure that satiety 
signals are not overridden by sensory or reward cues within the orbitofrontal cortex, to 
allow effective control of feeding behavior. 
Insight/Answers About Sensory Factors in Feeding Behavior Regulation 
 A major determinant of feeding behavior is the relative strength of satiety signals 
compared to the reward signals in response to food.  It is, therefore, important that satiety 
signals can overcome the influences of food reward cues, in order to avoid excessive 
eating and obesity.  It has been shown that obese individuals are similar to substance 
dependent individuals in that their reward response towards food cues is elevated 
compared to lean individuals (Gearhardt et al., 2011).  This means that obese individuals’ 
show greater activation within the orbitofrontal cortex, amygdala, etc. when presented 
with palatable food cues.  Interestingly, while these individuals have increased brain 
reward activity in response to anticipatory food cues, this reward activity and the 
associated dopaminergic release was decreased and lower compared to lean individuals 
during the actual process of eating (Gearhardt et al., 2011; Stice et al., 2008).  For these 
42 
 
reasons, similar to a drug dependent individual, an obese individual has an increased 
desire to eat, a reduced reward while eating, and in turn a problem with overeating to 
compensate for such effects.  Therefore, it seems that one approach to obesity treatment 
could parallel the types of methods used to treat drug dependent individuals. 
 It is important to recognize that sensory mechanisms from the environment (such 
as food smell, food taste, etc.) are largely processed within the orbitofrontal cortex, as are 
satiety signals (Rolls, 2011).  Individually, satiety/hunger is processed in different neural 
regions compared to olfactory, taste, and other external sensory cues.  The orbitofrontal 
cortex and the amygdala were the only areas of convergence between the different signals 
(Hinton et al., 2004).  This makes the orbitofrontal cortex very important in the decision 
making process for feeding behavior.  In order to allow for proper control of eating, it 
would seem that the orbitofrontal cortex would need to receive satiety signals that are 
stronger than the reward signals from food.  This would allow the orbitofrontal cortex to 
promote control of eating, resulting in decreased feeding behavior.  These principles 
allow for the potential for treatments that could help individuals control feeding behavior.  
It seems that a drug that inhibits the sensory receptors within the orbitofrontal cortex that 
respond to food reward cues (good smells, good tastes, etc.) could promote reduced 
eating.  Alternatively, a drug that could potentially enhance the sensitivity of satiety 
signals within the orbitofrontal cortex could also help regulate feeding behavior.  
Information within the orbitofrontal cortex is flows through multiple pathways (Barbas, 
2007), making multiple methods of manipulation of these signals seem possible.  While 
different precise mechanisms could be used, the key factor of this approach would be to 
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ensure that the orbitofrontal cortex is more strongly activated and influenced by satiety 
signals than by reward signals. 
 Another more simple approach to allow individuals to better control eating (based 
on sensory cue processing) could be to reduce the variety of food given to individuals.  It 
has been shown that sensory neuron responses to food cues (taste, sight, etc.) are food 
specific (Rolls et al., 1986).  This means that if an individual reaches satiety with the 
consumption of one food, then he/she will show reduced hypothalamic neural actitivity in 
response to that food’s sensory cues.  However, hypothalamic neural activity is 
practically unchanged in response to sensory cues from other food types which were not 
eaten to satiety (Rolls et al., 1986). This means that an individual will have continuous 
sensory motivations to eat when presented with a great variety of food types.  On the 
other hand, when presented with only one food type, the individual can reach satiety, 
have a reduced hypothalamic sensory response to the food, and in turn stop eating 
appropriately.  This could have potential clinical relevance, as individuals susceptible to 
obesity could better control their eating if they are presented with a smaller variety of 
food to potentially eat.  The study of sensory cues in the control of feeding behavior 
could allow for more invasive drug therapies for obesity, or more simple techniques such 
as reductions in the variety of foods served, which are both important. 
Current Knowledge About Feeding Entrained Circadian Clocks 
       In addition to sensory neuron mechanisms, the circadian clock, also has important 
effects on the regulation of feeding behavior.  While a circadian clock that responds to 
light entrainment conditions is located within the suprachiasmatic nucleus (SCN), the 
exact location and identity of the cells involved with a feeding centered circadian clock 
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are largely uncertain.  However, these different types of circadian clocks are interrelated 
and affect one another.  It is thought that the rhythms of feeding behavior are regulated 
largely by circadian oscillators within hypothalamic, corticolimbic, brainstem, and other 
cells (even cells outside of the brain).  It has been shown that the genetic circadian 
oscillators become entrained by feeding time (Mistlberger, 2011).  This means that cells 
within organisms shift their circadian rhythm in coordination with feeding.  For example, 
when rats were fed only in light periods (different from their typical behavior pattern), 
the circadian rhythm of neural, gastrointestinal, and other cells was shifted to correspond 
with the feeding time.  A shift in the circadian rhythm such as this corresponded with 
behavioral changes and modified food appetitive activity (seeking food, etc.) 
(Mistlberger, 2011).  Thus, perhaps an individual’s predisposition to eat or not to eat may 
be largely influenced by the function of the circadian clock.  It is known that circadian 
clock and metabolism are bi-directionally coupled, which means that each influences the 
other and allowing them to correspond with each other (Mistlberger, 2011).  Thus, 
hormonal and physiological functions vary throughout a time period based on a circadian 
rhythm.  This means that feeding behavior and its effects on body weight would differ 
depending on the status of the circadian clock.  Therefore, clinical therapies that utilize 
knowledge of the circadian biological feeding time clock could provide value in the 
treatment of obesity. 
Unanswered Question About Feeding Entrained Circadian Clocks 
       Through a strong understanding of how feeding behavior coordinates the circadian 
clock, and the corresponding physiological responses to the circadian clock, valuable 
clinical treatments for obesity can be developed.  However, the field has not determined 
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the real identity of the cells involved with the food-entrained circadian clock. There is 
uncertainty about the extent of which cells, (neural or other), are completely responsible 
for this circadian clock and its physiological implications.  The distribution or 
centralization of circadian oscillator cells and their location is uncertain.  Gaining 
understanding to this question provides real clinical and academic value.  Therefore, it is 
a goal of this thesis to provide insight into which cells are responsible for coordinating 
feeding behavior regulated by the circadian clock. 
Insight/Answers About Feeding Entrained Circadian Clocks 
 It has been shown that feeding has profound effects on the clock genes of 
mammals, which can induce oscillations that affect hormone and metabolic activity 
(Escobar et al., 2009).  Evidence suggests that the food entrained oscillator system is a 
product of oscillating cell types within both the central nervous system and the periphery.  
It appears likely that this food entrainable circadian clock is composed of a distributed 
network of oscillators, rather than one centralized oscillator complex.  There are 
numerous types of clock genes, which seem to have different levels of influence on the 
food-entrainable clock system (Feillet et al. 2006).  This study by showed that mutations 
within some clock genes, such as the Per2 gene found in the SCN, decreased the 
expression of food anticipatory activities, while other mutation types had little influence 
on food anticipatory activities.  These food anticipatory activities include body 
temperature increase, activity, and hormone releases prior to the predictable consumption 
time (Verwey & Amir, 2009).  One can recognize the importance of specific oscillator 
types within the food-entrainable clock, rather than a generalized importance of all 
circadian oscillators for the control of feeding behavior. 
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 It is likely that the food entrainable clock oscillators are distributed throughout the 
body.  This is evidenced by the fact that lesions in different brain nuclei regions affected 
food anticipatory activity, but did not eliminate such activity completely (Verwey & 
Amir, 2009).  Additionally, it has been found that circadian clock genes are located 
within the abdominal region organs (Davidson et al., 2003).  It seems possible that such 
oscillators could be distributed within the gastrointestinal system, as this is the system 
that coordinates feeding and processes food products.  Interestingly, a study by Davidson 
et al., 2003) suggested that the Per1 clock gene within the gastrointestinal tract was not 
likely responsible for coordinating the food entrainable clock.  However, this gene codes 
for only one type of circadian clock, and so it is possible that other oscillators within the 
gastrointestinal help coordinate the food entrainable clock.  Evidence such as this 
suggests that the coordinated study of oscillators within the periphery as well as in the 
central nervous system is the best approach to understanding the food entrainable 
circadian clock system.  Importantly, the food entrainable circadian clock is likely 
coordinated independently of the SCN, as feeding and behavioral rhythms can be 
maintained even without the function of the SCN oscillator system (Mistlberger & Antle, 
2011).  With many different potential oscillator types, encoded by different genes, it is 
difficult to determine which oscillators are most responsible for circadian rythms of 
feeding behavior.  Experimentation in which different combinations of oscillators are 
inhibited or oscillator genes are knocked out, and the resulting effects on feeding are 
observed, could be useful to identify the most important oscillators responsible for the 
food entrainable clock within mammals.  Perhaps special focus could be placed on 
oscillators which have neural or hormonal connections to the hypothalamus or 
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gastrointestinal tract, as these are the primary sites of feeding behavior regulation.  Just as 
there are medications that affect sleep, which is coordinated largely by the SCN’s 
circadian system, it seems possible that feeding and the food entrained circadian system 
can be also be manipulated medically.  These types of experiments could help determine 
the role of unique oscillator cells that are distributed throughout the body, and could 
allow for clinical treatments that manipulate the food entrained circadian system to 
produce desired health outcomes, such as healthy feeding and body weight. 
 
Conclusion 
 With the major issue of obesity within human society, it is quite important that the 
mechanisms that control feeding behavior are well understood.  The proper regulation of 
feeding behavior is absolutely necessary in order for mammals to achieve a healthy body 
weight.  Feeding must be carried out in a controlled fashion to achieve a sufficient intake 
of energy for metabolic processes, while avoiding excessive intake that could promote 
obesity.  By understanding the interacting mechanisms that allow for the regulation of 
feeding behavior, valuable health and clinical treatments can be developed that promote 
proper eating and reduce obesity within society. 
 The major components of the feeding behavior regulatory system, which include 
the central nervous system and gastrointestinal system, along with hormones, microbiota, 
and nutrient receptors, are coordinated in a sophisticated and interacting system.  There is 
a large amount of knowledge that has been gained about this system, but many questions 
remain unanswered.  This thesis has discussed the feeding behavior regulatory system 
and evaluated many of its unanswered questions.  Through research and analysis of the 
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known literature about the feeding behavioral regulatory system, and the brain/gut 
network in general, good insights have been gained.  This thesis has provided insight into 
the neural mechanisms that regulate eating, and can provide evaluations that promote 
further evaluation.  Using the known information about the feeding behavior regulatory 
system, along with the information of this thesis, it may be possible to further the pursuit 
of improved obesity treatments.  It is the goal of this thesis to evaluate the known 
information and provide new and profound answers and insight.  The issue of obesity and 
the role of the feeding behavior regulatory system in human health are very important for 
society.  It was this importance that was expressed by this thesis project.  The study of the 
mechanisms of feeding behavior regulation is a field of great importance for society, with 
amazing clinical and academic potential.  An integrated approach (as used in this thesis), 
which evaluates the entire interacting regulatory system within the context of the whole 
human or mammal, is the most realistic and fitting for clinical application.  For these 
reasons, this thesis was carried out, to help promote the progress of the scientific 
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